FDA Inspection 1207264 — ALS Group USA, Corp

ALS Group USA, Corp — FEI 2027219

The FDA completed an inspection of ALS Group USA, Corp on June 5, 2023 in Torrance, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 5, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Torrance, CA (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location